Gastric Cancer

ISSN: 1436-3291

Journal Home

Journal Guideline

Gastric Cancer Q1 Unclaimed

Springer Japan Japan
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Gastric Cancer, a joint official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, publishes significant studies related to stomach neoplasms. The journal welcomes original articles, case reports, short communications, and technical notes, which will be peer-reviewed by the editorial board. Letters to the Editor commenting on articles published in the journal or expressing views on topics concerning gastric cancer are also welcomed. Review articles are in principle solicited by the Editor. Meeting reports will include summaries of symposia or consensus achieved in the congresses of related associations. Why publish with us Our journal is a worldwide forum for surgeons, medical oncologists, epidemiologists and basic scientists, to investigate problems in gastric cancer. We cover all areas of treatment and biology relevant to gastric cancer, including genetic, biochemical, and cellular aspects. Our supportive and expert editorial team helps provide high levels of author satisfaction, with over 90% of our published authors reporting that they would definitely or probably publish in the journal again. It has an SJR impact factor of 2,136.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

3690 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Gastric Cancer

2,136

SJR Impact factor

99

H Index

90

Total Docs (Last Year)

338

Total Docs (3 years)

3391

Total Refs

2183

Total Cites (3 years)

320

Citable Docs (3 years)

6.82

Cites/Doc (2 years)

37.68

Ref/Doc

Comments

No comments ... Be the first to comment!



Best articles by citations

Prognostic factors in metastatic gastric cancer: results of a population-based, retrospective cohort study in Ontario

View more

Gastric carcinoid tumors with aggressive lymphovascular invasion and lymph node metastasis

View more

Lymph node metastasis and preoperative diagnosis of depth of invasion in early gastric cancer

View more

Subtotal versus total gastrectomy for T3 adenocarcinoma of the antrum

View more

Feasibility of weekly intraperitoneal versus intravenous paclitaxel therapy delivered from the day of radical surgery for gastric cancer: a preliminary safety analysis of the INPACT study, a randomized controlled trial

View more

Always randomize as late as possible

View more

Docetaxel and cisplatin in patients with advanced or recurrent gastric cancer: a multicenter phase I/II study

View more

Predictive value of MLH1 and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer

View more

Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer

View more

In-vitro effect of a combination of 5-fluorouracil (5-FU) and cisplatin (CDDP) on human gastric cancer cell lines: timing of cisplatin treatment

View more

Long-term quality of life after surgery for adenocarcinoma of the esophagogastric junction: extended gastrectomy or transthoracic esophagectomy?

View more

Subjects with TNF-A-857TT and -1031TT genotypes showed the highest Helicobacter pylori seropositive rate compared with those with other genotypes

View more
SHOW MORE ARTICLES

Methylation status of long interspersed element-1 in advanced gastric cancer and its prognostic implication

View more

Gastric linitis plastica: which role for surgical resection?

View more

Endoscopic resection of undifferentiated-type gastric carcinoma: an extreme step to be restrained?

View more

Connective tissue growth factor inhibits gastric cancer peritoneal metastasis by blocking integrin a3beta1-dependent adhesion

View more

Simultaneous early adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach associated with Helicobacter pylori infection

View more

Application of reduced-port laparoscopic total gastrectomy in gastric cancer preserving the pancreas and spleen

View more

Surgery for gastric cancer: 10-year experience worldwide

View more

Oncological outcomes of function-preserving gastrectomy for early gastric cancer: a multicenter propensity score matched cohort analysis comparing pylorus-preserving gastrectomy versus conventional distal gastrectomy

View more

Prognostic impacts of the combined positive score and the tumor proportion score for programmed death ligand-1 expression by double immunohistochemical staining in patients with advanced gastric cancer

View more

Minute gastric carcinoid tumor with regional lymph node metastasis

View more

Erratum: Gastric Cancer (2002) 5: 185-193

View more

Metastatic cancer to the stomach

View more

FAQS